Quest Diagnostics (DGX) PT Lowered to $98 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Quest Diagnostics (DGX) Reports Election of Denise Morrison to Board
February 19, 2019 5:06 PM ESTQuest Diagnostics (NYSE: DGX) today announced that its Board of Directors has elected Denise M. Morrison to serve as a director, effective February 18, 2019. Including Ms. Morrison, the company's Board has 11 members.
Ms. Morrison served as President and Chief Executive Officer of Campbell... More
Quest Diagnostics (DGX) PT Lowered to $100 at Baird
February 15, 2019 10:15 AM ESTBaird analyst Eric Coldwell lowered the price target on Quest Diagnostics (NYSE: DGX) to $100.00 (from $106.00) while maintaining a Outperform rating following the company's 4Q. Revenue missed the lowered November IR day target by ~$40M. $35M of downside due to additional reserve for payer denials,... More
